Please login to the form below

Not currently logged in
Email:
Password:

cardiomyopathy

This page shows the latest cardiomyopathy news and features for those working in and with pharma, biotech and healthcare.

Pfizer drug gets speedy FDA review for rare heart failure complication

Pfizer drug gets speedy FDA review for rare heart failure complication

The average life expectancy for people with transthyretin cardiomyopathy is three to five years from diagnosis, says Pfizer, which also got fast-track status for tafamidis last year. ... A further wrinkle is that Alnylam’s trials only enrolled subjects

Latest news

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    Annapurna brings a portfolio of four AAV-based gene therapy programmes at the preclinical stage for alpha-1 antitrypsin deficiency, hereditary angioedema, cardiomyopathy associated with Friedreich's ataxia and severe allergy.

  • Deal Watch table for September 2014 Deal Watch table for September 2014

    209. MyoKardia/ Sanofi. Licence and collaboration. 5. Three programmes for treatment of genetic forms of cardiomyopathy.

  • Pharma deals during September 2014 Pharma deals during September 2014

    Myokardia will develop two HCM (hypertrophic cardiomyopathy) programmes where it retains US commercialisation rights and Sanofi has ex-US rights; and a third DCM (dilated cardiomyopathy) programme will be developed by

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Jonathan Fox leaves AstraZeneca for MyoKardia Jonathan Fox leaves AstraZeneca for MyoKardia

    MyoKardia's genetically targeted approach and cutting-edge platform has the potential to fundamentally change the lives of patients with hypertrophic cardiomyopathy and dilated cardiomyopathy,” he said. “

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics